Selda Hakbilen

Selda Hakbilen

Auto-generated profile, based on publicly available information

Selda Hakbilen

Selcuk Universitesi

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
DTDilek Tezcan
Dilek Tezcan
MKMuslu Kazım Körez
Muslu Kazım Körez
SGSemral Gülcemal
Semral Gülcemal
SHSelda Hakbilen
Selda Hakbilen
TATuran AKDAG
Turan AKDAG
SYSema Yılmaz
Sema Yılmaz

26 October 2022 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
HÖHalil Özer
Halil Özer
DTDilek Tezcan
Dilek Tezcan
SHSelda Hakbilen
Selda Hakbilen
SGSemral Gülcemal
Semral Gülcemal
ÖTÖMER FARUK TOPALOĞLU
ÖMER FARUK TOPALOĞLU
SYSema Yılmaz
Sema Yılmaz

9 February 2022 in Modern Rheumatology
Verified
Journal Article
Closed access
PDF file
DTDilek Tezcan
Dilek Tezcan
DEDuygu Eryavuz
Duygu Eryavuz
ASAbdullah Sivrikaya
Abdullah Sivrikaya
MKMuslu Kazım Körez
Muslu Kazım Körez
SHSelda Hakbilen
Selda Hakbilen
SYSema Yılmaz
Sema Yılmaz
Familial Mediterranean fever (FMF) is an autoinflammatory syndrome characterized by recurrent episodes of fever and aseptic polyserositis. Subclinical inflammation generates a hidden threat to the development of FMF complications such as amyloidosis in attack-free intervals. The kynurenine pathway (KP) has been considered an important player in inflammation and immune response. The study was aimed to measure serum levels of KP metabolites in patients with FMF in the attack-free period. A total of 161 participants were recruited from the rheumatology department in this single-centre, case–control study. Participants meeting the eligibility criteria were divided into healthy controls (n = 80) and FMF (n = 81). The laboratory data were obtained from the electronic registration database. Serum tryptophan (TRP), kynurenine (KYN), kynurenic acid (KYNA), 3-hydroxyanthranilic acid, 3-hydroxykynurenine (3HK), and quinolinic acid (QUIN) concentrations were measured with tandem mass spectrometry. Laboratory findings of FMF patients and healthy controls subjects were compared and evaluated. Serum TRP and KYNA levels were significantly decreased in both FMF groups compared to the control group, while the levels of KYN, QUIN, 3HK, the KYN/TRP ratio, and red cell distribution width were higher. TRP degradation by the KP is increased in patients with FMF. KP metabolites can be useful in demonstrating subclinical inflammation.

26 September 2022 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
DTDilek Tezcan
Dilek Tezcan
DEDuygu Eryavuz
Duygu Eryavuz
ASAbdullah Sivrikaya
Abdullah Sivrikaya
SHSelda Hakbilen
Selda Hakbilen
MKMuslu Kazım Körez
Muslu Kazım Körez
SYSema Yılmaz
Sema Yılmaz

24 February 2025 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SHSelda Hakbilen
Selda Hakbilen
DTDilek Tezcan
Dilek Tezcan
DEDuygu Eryavuz
Duygu Eryavuz
SYSema Yılmaz
Sema Yılmaz
MKMuslu Kazım Körez
Muslu Kazım Körez
AUAli Unlu
Ali Unlu

1 January 2024 in Journal of Contemporary Medicine
Verified
Journal Article
Open access
PDF file
DTDilek Tezcan
Dilek Tezcan
MKMuslu Kazım Körez
Muslu Kazım Körez
SHSelda Hakbi̇len
Selda Hakbi̇len
MKMustafa Emin Kaygisiz
Mustafa Emin Kaygisiz
SGSemral Gülcemal
Semral Gülcemal
SYSema Yi̇lmaz
Sema Yi̇lmaz
Background: Ankylosing spondylitis (AS) is a chronic inflammatory disease which influences the proportion of immune cells. Tumor necrosis factor alpha (TNF-α) is essential in the pathogenesis of AS, and TNF inhibitors are the most effective treatment for AS patients. In recent years, routine blood parameters were reported as markers of systemic inflammation associated with the diagnosis and prognosis of numerous malignancies and chronic inflammatory diseases. This study aimed to investigate the relationship between haematological parameters and clinical parameters, disease severity and treatment response in AS patients treated with TNF inhibitors. Methods: A total of 326 participants were recruited from the rheumatology department in this study. Participants were divided into healthy controls (n = 178) and AS (n = 148). Neutrophil, lymphocyte, monocyte and platelet counts, neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR), platelet crit (PCT), mean platelet volume (MPV), red cell distribution width (RDW), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), cluster systemic inflammation index (AISI) and RPR levels were analyzed for each participant. They were compared between healthy control, AS patients during the pre-treatment phase and three months after the treatment. Results: RDW, PLR, NLR, MLR, SIRI, AISI and SII were higher than healthy controls and decreased with treatment except SIRI. The decrease in AISI and SII after treatment was significant in HLA-B27 positive patients. MPV was lower than healthy controls and increased with treatment. SII, SIRI and AISI were significantly higher in the active AS patients than in the inactive patient. Also, they were correlated with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Conclusion: SII, AISI, and SIRI may be valuable markers for demonstrating disease activation and evaluating the effectiveness of anti‐TNF‐α therapy.